Professor Michael Grimm

Back to

Professor Michael Grimm

Clinical Associate Dean

MB, BS (Hons), University of Sydney

PhD, Australian National University

FRACP, Royal Australasian College of Physicians

FGESA, Gastroenterological Society of Australia

Medicine & Health

School of Clinical Medicine

Professor Michael Grimm is the Clinical Associate Dean, and Head of the St George and Sutherland Clinical School.
��
Research Interests����
Prof Grimm supervises a number of research projects in the Department of Gastroenterology, St George and Sutherland Clinical School, Faculty of Medicine and Health. The research areas include: immunopathogenesis of inflammatory bowel diseases; novel therapeutic strategies in inflammatory bowel diseases; mucosal immunity and lymphocyte trafficking; regulatory T lymphocytes and other mechanisms controlling gastrointestinal immunity; the role of the appendix in gut immunity and IBD; clinical, psychological, physiological and microbial predictors of IBD relapse.
��
Broad Research Areas
Gastrointestinal Diseases; Immunology; Inflammation
��
Specific Research Keywords
Gastroenterology; Inflammatory Bowel Disease; Chemokines; Cytokines
��
Thesis topics for current �鶹��madou Medicine postgraduate research students
Role of leucocyte trafficking in modulating intestinal immunity and inflammation
Mechanisms of intestinal immune regulation in the intestine; Psychological factors,��gut microbial composition, and inflammation in the inflammatory bowel diseases.

Phone

+612 9113 2992

E-mail

m.grimm@unsw.edu.au

Book Chapters | 2019

Bensted K; Grimm M, 2019, 'Mucosal Immunology; Immunoglobulins, Lymphocytes and TH1, TH2 Responses', in Encyclopedia of Gastroenterology, Second Edition, pp. 586 - 594,

Book Chapters | 2019

Ma R; Liu F; Yap SF; Lee H; Leong RW; Riordan SM; Grimm MC; Zhang L, 2019, 'The Growth and Protein Expression of Inflammatory Bowel Disease-Associated Campylobacter concisus Is Affected by the Derivatives of the Food Additive Fumaric Acid', in Pandol SJ; Li Z (ed.), Xenobiotics and the Gut Microbiome in Health and Disease, Frontiers Media SA, pp. 96 - 110,

Book Chapters | 2019

Wu N; Yim HCH; Grimm M; El-Omar E, 2019, 'Epithelial Barrier Function', in Encyclopedia of Gastroenterology, Second Edition, pp. 300 - 313,
Journal articles | 2023

Mah C; Jayawardana T; Leong G; Koentgen S; Lemberg D; Connor SJ; Rokkas T; Grimm MC; Leach ST; Hold GL, 2023, 'Assessing the Relationship between the Gut Microbiota and Inflammatory Bowel Disease Therapeutics: A Systematic Review', Pathogens, 12,

Journal articles | 2022

Tavakoli P; Vollmer-Conna U; Hadzi-Pavlovic D; Vázquez-Campos X; Grimm MC; Vazquez Campos X, 2022, 'The Interplay Between Use of Biological Therapies, Psychological State, and the Microbiome in IBD', Frontiers in Medicine, 9, pp. 788992,

Journal articles | 2021

Cao RH; Grimm MC, 2021, 'Pregnancy and medications in inflammatory bowel disease', Obstetric Medicine, 14, pp. 4 - 11,

Journal articles | 2021

Lambert K; Pappas D; Miglioretto C; Javadpour A; Reveley H; Frank L; Grimm MC; Samocha-Bonet D; Hold GL, 2021, 'Systematic review with meta-analysis: dietary intake in adults with inflammatory bowel disease', Alimentary Pharmacology and Therapeutics, 54, pp. 742 - 754,

Journal articles | 2021

Tavakoli P; Vollmer-Conna U; Hadzi-Pavlovic D; Grimm MC, 2021, 'A Review of Inflammatory Bowel Disease: A Model of Microbial, Immune and Neuropsychological Integration', Public Health Reviews, 42,

Journal articles | 2021

Williams AJ; Paramsothy R; Wu N; Ghaly S; Leach S; Paramsothy S; Corte C; O'Brien C; Burke C; Wark G; Samocha-Bonet D; Lambert K; Ahlenstiel G; Wasinger V; Dutt S; Pavli P; Grimm M; Lemberg D; Connor S; Leong R; Hold G, 2021, 'Australia IBD Microbiome (AIM) Study: Protocol for a multicentre longitudinal prospective cohort study', BMJ Open, 11,

Journal articles | 2021

Wu N; Mah C; Koentgen S; Zhang L; Grimm MC; El-Omar E; Hold GL, 2021, 'Inflammatory bowel disease and the gut microbiota', Proceedings of the Nutrition Society, 80, pp. 424 - 434,

Journal articles | 2018

Liu F; Ma R; Tay CYA; Octavia S; Lan R; Chung HKL; Riordan SM; Grimm MC; Leong RW; Tanaka MM; Connor S; Zhang L, 2018, 'Genomic analysis of oral Campylobacter concisus strains identified a potential bacterial molecular marker associated with active Crohn's disease', Emerging Microbes and Infections, 7, pp. 1 - 14,

Journal articles | 2018

Ma R; Liu F; Yap SF; Lee H; Leong RW; Riordan SM; Grimm MC; Zhang L, 2018, 'The growth and protein expression of Inflammatory Bowel disease-associated Campylobacter concisus is affected by the derivatives of the food additive fumaric acid', Frontiers in Microbiology, 9, pp. 896,

Journal articles | 2017

Chung HKL; Tay A; Octavia S; Chen J; Liu F; Ma R; Lan R; Riordan SM; Grimm MC; Zhang L, 2017, 'Erratum: Genome analysis of Campylobacter concisus strains from patients with inflammatory bowel disease and gastroenteritis provides new insights into pathogenicity', Scientific reports, 7, pp. 41113,

Journal articles | 2017

Liu F; Ma R; Riordan SM; Grimm MC; Liu L; Wang Y; Zhang L, 2017, 'Azathioprine, mercaptopurine, and 5-aminosalicylic acid affect the growth of IBD-associated Campylobacter species and other enteric microbes', Frontiers in Microbiology, 8,

Journal articles | 2017

Luo A; Leach ST; Barres R; Hesson LB; Grimm MC; Simar D, 2017, 'The microbiota and epigenetic regulation of t helper 17/regulatory T cells: In search of a balanced immune system', Frontiers in Immunology, 8, pp. 417,

Journal articles | 2017

Wang Y; Liu F; Zhang X; Chung HKL; Riordan SM; Grimm MC; Zhang S; Ma R; Lee SA; Zhang L, 2017, 'Campylobacter concisus genomospecies 2 is better adapted to the human gastrointestinal tract as compared with Campylobacter concisus genomospecies 1', Frontiers in Physiology, 8, pp. 543,

Journal articles | 2016

Chung HKL; Tay A; Octavia S; Chen J; Liu F; Ma R; Lan R; Riordan SM; Grimm MC; Zhang L, 2016, 'Genome analysis of Campylobacter concisus strains from patients with inflammatory bowel disease and gastroenteritis provides new insights into pathogenicity', Scientific Reports, 6, pp. 38442,

Journal articles | 2016

Mahendran V; Liu F; Riordan SM; Grimm MC; Tanaka MM; Zhang L, 2016, 'Examination of the effects of Campylobacter concisus zonula occludens toxin on intestinal epithelial cells and macrophages', Gut Pathogens, 8, pp. 18,

Journal articles | 2015

Cheluvappa R; Eri R; Luo AS; Grimm MC, 2015, 'Modulation of interferon activity-associated soluble molecules by appendicitis and appendectomy limits colitis-identification of novel anti-colitic targets', Journal of Interferon and Cytokine Research, 35, pp. 108 - 115,

Journal articles | 2015

Ma R; Sapwell N; Chung HKL; Lee H; Mahendran V; Leong RW; Riordan SM; Grimm MC; Zhang L, 2015, 'Investigation of the effects of ph and bile on the growth of oral campylobacter concisus strains isolated from patients with inflammatory bowel disease and controls', Journal of Medical Microbiology, 64, pp. 438 - 445,

Journal articles | 2015

Mahendran V; Octavia S; Demirbas OF; Sabrina S; Ma R; Lan R; Riordan SM; Grimm MC; Zhang L, 2015, 'Delineation of genetic relatedness and population structure of oral and enteric Campylobacter concisus strains by analysis of housekeeping genes', Microbiology (United Kingdom), 161, pp. 1600 - 1612,

Journal articles | 2014

Cheluvappa R; Eri R; Luo AS; Grimm MC, 2014, 'Endothelin and vascular remodelling in colitis pathogenesis—Appendicitis and appendectomy limit colitis by suppressing endothelin pathways', International Journal of Colorectal Disease, 29, pp. 1321 - 1328,

Journal articles | 2014

Cheluvappa R; Luo AS; Grimm MC, 2014, 'Autophagy suppression by appendicitis and appendectomy protects against colitis', Inflammatory Bowel Diseases, 20, pp. 847 - 855,

Journal articles | 2014

Cheluvappa R; Luo AS; Grimm MC, 2014, 'T helper type 17 pathway suppression by appendicitis and appendectomy protects against colitis', Clinical and Experimental Immunology, 175, pp. 316 - 322,

Journal articles | 2014

Lee GSC; Grimm MC, 2014, 'Recreating the intestinal macrophage in vitro: a potential role for stromal factors', JOURNAL OF CROHNS & COLITIS, 8, pp. S74 - S75,

Journal articles | 2014

Lee H; Ma R; Grimm MC; Riordan SM; Lan R; Zhong L; Raftery M; Zhang L, 2014, 'Examination of the anaerobic growth of Campylobacter concisus strains', International Journal of Microbiology, 2014,

Journal articles | 2014

Luo AS; Lim A; Jung HJ; Phillips PA; Grimm MC, 2014, 'Retinoic acid is required for the generation of protective appendiceal regulatory T cells', JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY, 29, pp. 20 - 20,

Journal articles | 2014

Scicluna HA; Grimm MC; Jones PD; Pilotto LS; McNeil HP, 2014, 'Improving the transition from medical school to internship - Evaluation of a preparation for internship course', BMC Medical Education, 14,

Journal articles | 2014

Yeung L; Grimm MC, 2014, 'The impact of appendicitis on ROR gamma t plus innate lymphoid cells', JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY, 29, pp. 21 - 21,

Journal articles | 2014

Zhang L; Lee H; Grimm MC; Riordan SM; Day AS; Lemberg DA, 2014, 'Campylobacter concisus and inflammatory bowel disease', World Journal of Gastroenterology, 20, pp. 1259 - 1267,

Journal articles | 2013

Handford C; Lemon JA; Grimm M; Vollmer-Conna US, 2013, 'Empathy as a Function of Clinical Exposure - Reading Emotion in the Eyes', PLoS ONE, 8, pp. e65159,

Journal articles | 2013

Ismail Y; Lee H; Riordan S; Grimm M; Zhang L, 2013, 'The effects of oral and enteric campylobacter concisus strains on expression of TLR4, MD-2, TLR2, TLR5 and COX-2 in HT-29 cells', PLoS ONE, 8, pp. Article number e56888,

Journal articles | 2013

Lee AYS; Eri R; Lyons AB; Grimm MC; Korner H, 2013, 'CC chemokine ligand 20 and its cognate receptor CCR6 in mucosal T cell immunology and inflammatory bowel disease: Odd couple or axis of evil?', Frontiers in Immunology, 4,

Journal articles | 2013

Luo AS; Jung HJ; Phillips PA; Grimm MC, 2013, 'The mechanisms of regulatory T cell expansion following appendicitis induction', JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY, 28, pp. 11 - 11,

Journal articles | 2013

Mahendran V; Tan YS; Riordan SM; Grimm MC; Day AS; Lemberg DA; Octavia S; Lan R; Zhang L, 2013, 'The Prevalence and Polymorphisms of Zonula Occluden Toxin Gene in Multiple Campylobacter concisus Strains Isolated from Saliva of Patients with Inflammatory Bowel Disease and Controls', PLoS ONE, 8,

Journal articles | 2013

Zbaras B; Sam LN; Grimm MC, 2013, 'Thrombotic thrombocytopenic purpura associated with adalimumab (Humira) treatment in Crohn disease', Internal Medicine Journal, 43, pp. 216 - 217,

Journal articles | 2012

McNeil HP; Scicluna H; Boyle P; Grimm MC; Gibson KA; Jones PD, 2012, 'Successful development of generic capabilities in an undergraduate medical education program', Higher Education Research and Development, 31, pp. 525 - 539,

Journal articles | 2011

Cheluvappa R; Luo AS; Palmer C; Grimm M, 2011, 'Protective pathways against colitis mediated by appendicitis and appendectomy.', Clinical and Experimental Immunology, 165, pp. 393 - 400,

Journal articles | 2011

Mahendran V; Riordan S; Grimm M; Tran TAT; Major J; Kaakoush NO; Mitchell HM; Zhang L, 2011, 'Prevalence of Campylobacter species in adult Crohn's disease and the preferential colonization sites of Campylobacter species in the human intestine', PLoS ONE, 6, pp. 1 - 7,

Journal articles | 2010

Cheluvappa R; Denning GM; Lau GW; Grimm M; Hilmer SN; Le couteur DG, 2010, 'Pathogenesis of the hyperlipidemia of Gram-negative bacterial sepsis may involve pathomorphological changes in liver sinusoidal endothelial cells.', International Journal of Infectious Diseases, 14, pp. 857 - 867,

Journal articles | 2010

Cheluvappa R; Luo AS; Grimm MC, 2010, 'Gene set enrichment analysis identifies important protective pathways utilised by appendicitis and appendectomy for ameliorating colitis', JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY, 25, pp. A3 - A3,

Journal articles | 2010

Jurawan R; Middlemiss C; Grimm MC, 2010, 'Colonoscopic polypectomy in chronic colitis: a five-year review', JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY, 25, pp. A63 - A64,

Journal articles | 2010

Zhang L; Budman V; Day AS; Mitchell HM; Lemberg DA; Riordan SM; Grimm M; Leach ST; Ismail Y, 2010, 'Isolation and detection of Campylobacter concisus from saliva of healthy individuals and patients with inflammatory bowel disease', Journal of Clinical Microbiology, 48, pp. 2965 - 2967

Journal articles | 2009

Cheluvappa R; Denning GM; Lau GW; Grimm MC; Hilmer SN; Le Couteur DG, 2009, 'Pseudomonas aeruginosa and the hyperlipidaemia of sepsis', Pathology, 41, pp. 615 - 621,

Journal articles | 2009

Grimm M, 2009, 'New and emerging therapies for inflammatory bowel diseases', Journal of Gastroenterology and Hepatology, 24, pp. S69 - S74

Journal articles | 2008

Gibson KA; Boyle P; Black DA; Cunningham M; Grimm M; McNeil HP, 2008, 'Enhancing evaluation in an undergraduate medical education program', Academic Medicine, 83, pp. 787 - 793

Journal articles | 2008

Grimm M; Ng W, 2008, 'Road most traveled: Gut-specific migration signals and leucocyte entry to the intestine', Journal of Gastroenterology and Hepatology, 23, pp. 1775 - 1776

Journal articles | 2008

Lee GS; Grimm MC; Borges L; Tedla N, 2008, 'Leukocyte immunoglobulin-like receptors in the human colon', GASTROENTEROLOGY, 134, pp. A511 - A511,

Journal articles | 2008

Lee GS; Grimm MC; Borges L; Tedla N, 2008, 'T1227 Leukocyte Immunoglobulin-Like Receptors in the Human Colon', Gastroenterology, 134, pp. A - 511,

Journal articles | 2007

Ng W; Hampartzoumian T; Lloyd AR; Grimm M, 2007, 'A murine model of appendicitis and the impact of inflammation on appendiceal lymphocyte constituents', Clinical and Experimental Immunology, 150, pp. 169 - 178

Journal articles | 2006

Chin BW; Grimm MC; Connor SJ; Leong RW, 2006, 'Managing inflammatory bowel disease', Medicine Today, 7, pp. 14 - 23

Journal articles | 2006

Ng WW; Lloyd AR; Grimm M, 2006, 'Appendicitis protects against colitis: an exploration of immune mechanisms', Journal of Gastroenterology and Hepatology, 21, pp. A263 - A263,

Journal articles | 2005

Jackson NE; Tedla NT; Geczy C; Collins AM; Grimm M; Hampartzoumian T; Hunt JE; Wang H; McNeil HP, 2005, 'IL-15 induces mast cell migration via a pertussis toxin-sensitive receptor', European Journal of Immunology, 35, pp. 2376 - 2385

Journal articles | 2005

McNeil HP; Grimm M, 2005, 'Achieving equal standards in medical student education: is a national exit examination the answer?', Medical Journal of Australia, 183, pp. 166 - 167

Journal articles | 2005

Newman R; Cuan N; Hampartzoumian T; Connor SJ; Lloyd AR; Grimm M, 2005, 'Vasoactive intestinal peptide impairs leucocyte migration but fails to modify experimental murine colitis', Clinical and Experimental Immunology, 139, pp. 411 - 420

Journal articles | 2004

Connor SJ; Paraskevopoulos N; Newman R; Cuan N; Hampartzoumian T; Lloyd AR; Grimm M, 2004, 'CCR2 expressing CD4+T lymphocytes are preferentially recruited to the ileum in Crohn's disease', Gut, 53, pp. 1287 - 1294

Journal articles | 2004

Grimm M; Pavli P, 2004, 'NOD2 mutations and Crohn`s disease: are Paneth cells and theirantimicrobial peptides the link?', Gut, 53, pp. 1558 - 1560

Journal articles | 2003

Grimm M; Newman R; Hassim Z; Cuan N; Connor SJ; Wang J; Oppenheim JJ; Lloyd AR, 2003, 'Vasoactive intestinal peptide acts as a potent suppressor of inflammation in vivo by trans-deactivating chemokine receptors', Journal of Immunology, 171, pp. 4990 - 4994

Journal articles | 2003

Grimm MC; Newman R; Hassim Z; Cuan N; Connor SJ; Le Y; Wang JM; Oppenheim JJ; Lloyd AR, 2003, 'Cutting Edge: Vasoactive Intestinal Peptide Acts as a Potent Suppressor of Inflammation In Vivo by Trans-Deactivating Chemokine Receptors', Journal of Immunology, 171, pp. 4990 - 4994,

Journal articles | 2003

Wolfrum S; Grimm M; Heidbreder M; Dendorfer A; Katus HA; Liao JK; Richardt G, 2003, 'Acute reduction of myocardial infarct size by a hydroxymethyl glutaryl coenzyme a reductase inhibitor is mediated by endothelial nitric oxide synthase', Journal of Cardiovascular Pharmacology, 41, pp. 474 - 480,

Journal articles | 2002

Grimm M; Spiecker M; De Caterina R; Shin WS; Liao JK, 2002, 'Inhibition of major histocompatibility complex class II gene transcription by nitric oxide and antioxidants', Journal of Biological Chemistry, 277, pp. 26460 - 26467,

Journal articles | 2002

Grimm M, 2002, 'Inflammatory bowel disease and inflammatory molecules: chicken, eggs and therapeutic targets', Journal of Gastroenterology and Hepatology, 17, pp. 935 - 937

Journal articles | 2001

Amansec SG; Connor SJ; Cardillo R; Cuan N; Grimm MC; Conway P, 2001, 'AMELIORATION OF MURINE TNBS COLITIS USING PREBIOTICS', Journal of Gastroenterology and Hepatology, 16, pp. 6 - 6,

Journal articles | 2001

Connor SJ; Cardillo R; Cuan N; Amansec S; Conway P; Lloyd AR; Grimm MC, 2001, 'Amelioration of TNBS colitis in mice using preblotics', Gastroenterology, 120, pp. A82 - A82,

Journal articles | 2001

Connor SJ; Grimm MC, 2001, 'Heparin as an anti-inflammatory agent: It's no GAG to forget about chemokines [3]', Gut, 48, pp. 738,

Journal articles | 2001

Grimm M; Kurz T; Schwarz M; Richardt D; Schäfer U; Katus HA; Richardt G, 2001, 'Presynaptic regulation of cardiac norepinephrine release in ischemia', Journal of Cardiovascular Pharmacology, 38, pp. 58 - 68,

Journal articles | 2001

Grimm MC, 2001, 'Inflammatory bowel disease - Genes, germs and the gastrointestinal immune system', Today's Life Science, 13, pp. 24 - 30

Journal articles | 2001

Jain D; Grimm M; Bartels C; Bechtel M; Tölg R; Hartmann F; Katus HA; Sievers HH; Richardt G, 2001, 'Early post-operative haemodynamic and neurohumoral follow-up after endoaneurysmorrhaphy', Journal of Clinical and Basic Cardiology, 4, pp. 165 - 167

Journal articles | 2001

Mortimore M; Gibson PR; Selby WS; Radford-Smith GL; Florin THJ; Ooi K; Wood L; Macrae F; Lachal S; Connell W; Crotty B; Griffin S; Grimm M; James S; Katelaris P; Pavli P, 2001, 'Early Australian experience with infliximab, a chimeric antibody against tumour necrosis factor-α, in the treatment of Crohn's disease: Is its efficacy augmented by steroid-sparing immunosuppressive therapy?', Internal Medicine Journal, 31, pp. 146 - 150,

Journal articles | 2001

Salley J; Grimm M; Sismanis A; Spencer RF; Wise CM, 2001, 'Methotrexate in the management of immune mediated cochleovestibular disorders: Clinical experience with 53 patients', Journal of Rheumatology, 28, pp. 1037 - 1040

Journal articles | 2001

Takemoto M; Node K; Nakagami H; Liao Y; Grimm M; Takemoto Y; Kitakaze M; Liao JK, 2001, 'Statins as antioxidant therapy for preventing cardiac myocyte hypertrophy', Journal of Clinical Investigation, 108, pp. 1429 - 1437,

Journal articles | 2001

Zotz RJ; Zirlik A; Raeder T; Hahn M; Binner C; Ullmann C; Grimm M; Schuler G, 2001, 'Three-dimensional visualization of coronary arteries in excised hearts', Journal of the American Society of Echocardiography, 14, pp. 11 - 19,

Journal articles | 2000

Cardillo R; Hassim Z; Tedla N; Lloyd AR; Grimm MC, 2000, 'VIP desensitizes chemokine receptors and impairs leukocyte trafficking and inflammation in vivo.', GASTROENTEROLOGY, 118, pp. A357 - A357,

Journal articles | 2000

Dalhoff K; Kothe H; Grimm M; Katus HA; Katus HA, 2000, 'Inflammation, CSE-Hemmer und Chlamydia pneumoniae Inflammation, Statins and Chlamydia pneumoniae', Herz Kreislauf, 32, pp. 123 - 125

Journal articles | 2000

Davenport ; Grimm M; Lloyd DH, 2000, 'A homing seletion hypothesis for T-cell trafficking', Immunology Today, pp. 315 - 317

Journal articles | 2000

Davenport MP; Grimm MC; Lloyd AR, 2000, 'A homing selection hypothesis for T-cell trafficking', Immunology Today, 21, pp. 315 - 317

Journal articles | 2000

Richardt G; Grimm M; Haass M, 2000, 'Sympathetic nerves and coronary heart disease', Deutsche Medizinische Wochenschrift, 125, pp. 159 - 164,

Journal articles | 1999

Biragyn A; Tani K; Grimm MC; Weeks S; Kwak LW, 1999, 'Genetic fusion of chemokines to a self tumor antigen induces protective, T-cell dependent antitumor immunity', Nature Biotechnology, 17, pp. 253 - 258,

Journal articles | 1999

Grimm MC; Hassim Z; Lloyd AR; Oppenheim JJ, 1999, 'Chemokine receptors are inhibited by vasoactive intestinal peptide: Desensitization of HIV-1 co-receptors', GASTROENTEROLOGY, 116, pp. A728 - A728,

Journal articles | 1999

Powell L; Selby W; McCaughan G; Grimm MC, 1999, 'Fifty years of gastroenterology in Australia', Journal of Gastroenterology and Hepatology (Australia), 14, pp. 179 - 193,

Journal articles | 1999

Salcedo R; Wasserman K; Young HA; Grimm MC; Howard OMZ; Anver MR; Kleinman HK; Murphy WJ; Oppenheim JJ, 1999, 'Vascular endothelial growth factor and basic fibroblast growth factor induce expression of CXCR4 on human endothelial cells. In vivo neovascularization induced by stromal-derived factor-1α', American Journal of Pathology, 154, pp. 1125 - 1135,

Journal articles | 1999

Su SB; Gong W-H; Gao J-L; Shen W-P; Grimm MC; Deng X; Murphy PM; Oppenheim JJ; Wang JM, 1999, 'T20/DP178, an Ectodomain Peptide of Human Immunodeficiency Virus Type 1 gp41, Is an Activator of Human Phagocyte N-Formyl Peptide Receptor', Blood, 93, pp. 3885 - 3892,

Journal articles | 1999

Su SB; Gong W; Grimm M; Utsunomiya I; Sargeant R; Oppenheim JJ; Wang JM, 1999, 'Inhibition of tyrosine kinase activation blocks the down-regulation of CXC chemokine receptor 4 by HIV-1 gp120 in CD4⁺ T cells', Journal of Immunology, 162, pp. 7128 - 7132

Journal articles | 1999

Su SB; Gong WH; Gao JL; Shen WP; Grimm MC; Deng X; Murphy PM; Oppenheim JJ; Wang JM, 1999, 'T20/DP178, an ectodomain peptide of human immunodeficiency virus type 1 gp41, is an activator of human phagocyte N-formyl peptide receptor', Blood, 93, pp. 3885 - 3892,

Journal articles | 1999

Su SB; Ueda H; Howard OMZ; Grimm MC; Gong W; Ruscetti FW; Oppenheim JJ; Wang JM, 1999, 'Inhibition of the expression and function of chemokine receptors on human CD4+ leukocytes by HIV-1 envelope protein gp 120', Chemical Immunology, 72, pp. 141 - 160,

Journal articles | 1998

Gong W; Howard OMZ; Turpin JA; Grimm MC; Ueda H; Gray PW; Raport CJ; Oppenheim JJ; Wang JM, 1998, 'Monocyte chemotactic protein-2 activates CCR5 and blocks CD4/CCR5- mediated HIV-1 entry/replication', Journal of Biological Chemistry, 273, pp. 4289 - 4292,

Journal articles | 1998

Grimm MC; Ben-Baruch A; Taub DD; Howard OMZ; Resau JH; Wang JM; Ali H; Richardson R; Snyderman R; Oppenheim JJ, 1998, 'Opiates transdeactivate chemokine receptors: δ and μ opiate receptor- mediated heterologous desensitization', Journal of Experimental Medicine, 188, pp. 317 - 325,

Journal articles | 1998

Ueda H; Howard OMZ; Grimm MC; Su SB; Gong W; Evans G; Ruscetti FW; Oppenheim JJ; Wang JM, 1998, 'HIV-1 envelope gp41 is a potent inhibitor of chemoattractant receptor expression and function in monocytes', Journal of Clinical Investigation, 102, pp. 804 - 812,

Journal articles | 1998

Wang JM; Ueda H; Howard OMZ; Grimm MC; Chertov O; Gong X; Gong W; Resau JH; Broder CC; Evans G; Arthur LO; Ruscetti FW; Oppenheim JJ, 1998, 'HIV-1 envelope gp120 inhibits the monocyte response to chemokines through CD4 signal-dependent chemokine receptor down-regulation', Journal of Immunology, 161, pp. 4309 - 4317

Journal articles | 1997

Ben-Baruch A; Grimm M; Bengali K; Evans GA; Chertov O; Wang JM; Howard OMZ; Mukaida N; Matsushima K; Oppenheim JJ, 1997, 'The Differential Ability of IL-8 and Neutrophil-Activating Peptide-2 to Induce Attenuation of Chemotaxis Is Mediated by Their Divergent Capabilities to Phosphorylate CXCR2 (IL-8 Receptor B)', Journal of Immunology, 158, pp. 5927 - 5933

Journal articles | 1996

Grimm MC; Doe WF, 1996, 'Chemokines in inflammatory bowel disease mucosa: Expression of RANTES, Macrophage Inflammatory Protein (MIP)-1α, MIP-1β, and γ-interferon-inducible protein-10 by macrophages, lymphocytes, endothelial cells, and granulomas', Inflammatory Bowel Diseases, 2, pp. 88 - 96,

Journal articles | 1996

Grimm MC; Elsbury SKO; Pavli P; Doe WF, 1996, 'Enhanced expression and production of monocyte chemoattractant protein-1 in inflammatory bowel disease mucosa', Journal of Leukocyte Biology, 59, pp. 804 - 812,

Journal articles | 1996

Grimm MC; Elsbury SKO; Pavli P; Doe WF, 1996, 'Interleukin 8: Cells of origin in inflammatory bowel disease', Gut, 38, pp. 90 - 98,

Journal articles | 1996

Pavli P; Cavanaugh J; Grimm M, 1996, 'Inflammatory bowel disease: Germs or genes?', Lancet, 347, pp. 1198,

Journal articles | 1995

GRIMM M; PULLMAN W; BENNETT G; SULLIVAN P; PAVLI P; DOE W, 1995, 'Direct evidence of monocyte recruitment to inflammatory bowel disease mucosa', Journal of Gastroenterology and Hepatology, 10, pp. 387 - 395,

Journal articles | 1995

Grimm MC; Pavli P; Van de Pol E; Doe WF, 1995, 'Evidence for a CD14⁺ population of monocytes in inflammatory bowel disease mucosa - implications for pathogenesis', Clinical and Experimental Immunology, 100, pp. 291 - 297,
Conference Abstracts | 2022

Tavakoli P; Wu N; Shapiro AJ; Sanchez-Lomba B; Pipicella JL; Lo L; Williams A-J; Ghaly S; Leach ST; Corte C; Burke C; Samocha-Bonet D; Lambert K; Wasinger V; Dutt S; Pavli P; Grimm MC; Lemberg D; Connor S; Leong R; Hold G; Paramsothy R; O'Brien C, 2022, 'A snapshot of inflammatory bowel disease in Australia: Interim analysis of the Australian IBD Microbiome (AIM) Study cohort', in JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY, WILEY, Vol. 37, pp. 159 - 159,

Conference Abstracts | 2021

Tavakoli P; Vollmer-Conna U; Hadzi-Pavlovic D; Grimm MC; Vazquez-Campos X, 2021, 'Biological therapies and bio-microbial dynamics in inflammatory bowel diseases', in JOURNAL OF CROHNS & COLITIS, OXFORD UNIV PRESS, Vol. 15, pp. S468 - S469,

Conference Papers | 2020

Tavakoli P; Vollmer-Conna U; Campos XV; Hadzi-Pavlovic D; Grimm M, 2020, 'Biological therapies and the trajectories of biopsychological factors in inflammatory bowel diseases', in JOURNAL OF CROHNS & COLITIS, OXFORD UNIV PRESS, pp. S296 - S297,

Conference Abstracts | 2020

Tavakoli P; Vollmer-Conna U; Hadzi-Pavlovic D; Vazquez-Campos X; Grimm M, 2020, 'Biological therapies and the trajectories of biopsychological factors in inflammatory bowel diseases', in JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY, WILEY, Vol. 35, pp. 108 - 108,

Conference Abstracts | 2020

Tavakoli P; Vollmer-Conna U; Vazquez Campos X; Hadzi-Pavlovic D; Grimm M, 2020, 'P289 Biological therapies and the trajectories of biopsychological factors in inflammatory bowel diseases', in Journal of Crohn's and Colitis, Oxford University Press (OUP), Vol. 14, pp. S296 - S297,

Conference Abstracts | 2019

Chiou J; Pavendranathan G; Grimm M, 2019, 'Real-world utility of fecal calprotectin in the management of patients with inflammatory bowel disease: To what end?', in JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY, WILEY, Vol. 34, pp. 150 - 151,

Conference Abstracts | 2019

Tavakoli P; Vollmer-Conna U; Hadzi-Pavlovic D; Vazquez-Campos X; Grimm M, 2019, 'Longitudinal course of inflammatory bowel diseases: A model of microbial, immune, and neuropsychological integration', in JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY, WILEY, Vol. 34, pp. 140 - 142,

Conference Posters | 2019

Tavakoli P; Vollmer-Conna U; Hadzi-Pavlovik D; Vazquez-Campos X; Grimm M, 2019, 'P234 Longitudinal course of inflammatory bowel diseases: a model of microbial, immune, and neuropsychological integration', Vol. 13, pp. S213 - S214,

Conference Abstracts | 2015

Chen G; Grimm MC, 2015, 'Hospital admission for acute diarrhoea: better off under a gastroenterologist or not?', in JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY, WILEY-BLACKWELL, Vol. 30, pp. 13 - 14,

Conference Abstracts | 2015

Liu F; Ma R; Lee H; Riordan SM; Grimm MC; Leong RW; Zhang LI, 2015, 'Bile induces the release of zonula occludens toxin by Campylobacter concisus: a unique pathogenic mechanism by which oral Campylobacter species initiate a subgroup of human IBD', in Journal of Gastroenterology and Hepatology, Wiley: 12 months, Vol. 30, pp. 148 - 148

Conference Abstracts | 2014

Ma R; Sapwell N; Lee H; Mahendran V; Leong RW; Grimm MC; Riordan SM; Zhang L, 2014, 'The effects of gastrointestinal environmental factors on Campylobacter concisus growth', in JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY, WILEY-BLACKWELL, Vol. 29, pp. 22 - 22,

Conference Abstracts | 2014

Mahendran V; Lee H; Liu F; Zhang L, 2014, 'Detection of the zonula occludens toxin expressed in Campylobacter concisus strains (note this manual entry previously had incorrect article title, M Potter April 2015)', in JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY, WILEY-BLACKWELL, Vol. 29 (Suppl. 2), pp. 10 - 26,

Conference Abstracts | 2013

Mahendran V; Lee HY; Tan YS; Riordan SM; Grimm MC; Day AS; Lemberg DA; Octavia S; Lan R; Zhang L, 2013, 'The association between a tight junction toxin gene in Campylobacter concisus and inflammatory bowel disease', in JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY, WILEY-BLACKWELL, Vol. 28, pp. 14 - 14,

Conference Abstracts | 2010

Wong SM; Day A; Lemberg D; Riordan S; Grimm MC; Budiman V; Mitchell H; Ismail Y; Zhang L, 2010, 'Antibiotic susceptibility of Campylobacter concisus isolated from patients with inflammatory bowel disease', in JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY, WILEY-BLACKWELL PUBLISHING, INC, Vol. 25, pp. A80 - A80,

Conference Abstracts | 2001

Connor SJ; Cardillo R; Cuan N; Amansec S; Conway P; Lloyd AR; Grimm MC, 2001, 'Amelioration of TNBS colitis in mice using prebiotics', in GASTROENTEROLOGY, W B SAUNDERS CO, Vol. 120, pp. A82 - A82,

Conference Abstracts | 2000

Connor SJ; Hassim Z; Cardillo R; Lloyd AR; Grimm MC, 2000, 'Chemokine receptor expression and function in lamina propria mononuclear cells of the human colon.', in GASTROENTEROLOGY, W B SAUNDERS CO, Vol. 118, pp. A355 - A355,

Conference Papers | 1999

Su SB; Gong WH; Gao JL; Shen WP; Grimm MC; Murphy PM; Oppenheim JJ; Wang JM, 1999, 'T20/DP 178, an ectodomain peptide of HIV-1 gp41, is a potent activator of human phagocyte N-formyl peptide receptor', in FASEB JOURNAL, FEDERATION AMER SOC EXP BIOL, pp. A293 - A293,

Conference Papers | 1998

Grimm MC; Ben-Baruch A; Taub DD; Howard OMZ; Wang JM; Oppenheim JJ, 1998, 'Opiate inhibition of chemokine-induced chemotaxis', in Annals of the New York Academy of Sciences, pp. 9 - 20,

Conference Papers | 1998

Howard OMZ; Korte T; Tarasova NI; Grimm M; Turpin JA; Rice WG; Michejda CJ; Blumenthal R; Oppenheim JJ, 1998, 'Small molecule inhibitor of HIV-1 cell fusion blocks chemokine receptor- mediated function', in Journal of Leukocyte Biology, pp. 6 - 13,

1993 Gastroenterological Society of Australia Young Investigator Award

1996 Fenner Medal for outstanding PhD thesis, John Curtin School of Medical Research, ANU

1996 Fulbright Postdoctoral Fellowship

2001 �鶹��madou Vice Chancellor’s Teaching and Research Award

2008 �鶹��madou Faculty of Medicine Award for Outstanding Contributions to Student Learning

2017 Outstanding Clinician Award, Gastroenterological Society of Australia

�鶹��madou

Follow

Professor Michael Grimm